Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

Inge Sluis; H de Groot-Kruseman; M te Loo; WJE Tissing; C van den Bos; GJL Kaspers; M Bierings; WJW Kollen; T Konig; U Pichlmeier; HJ Kuhnel; Rob Pieters

doi:10.1002/pbc.27083

Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

Inge Sluis, H de Groot-Kruseman, M te Loo, WJE Tissing, C van den Bos, GJL Kaspers, M Bierings, WJW Kollen, T Konig, U Pichlmeier, HJ Kuhnel, Rob Pieters

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

19 Citations (Scopus)

Original language	Undefined/Unknown
Article number	e27083
Journal	Pediatric Blood & Cancer
Volume	65
Issue number	8
DOIs	https://doi.org/10.1002/pbc.27083
Publication status	Published - 2018

Research programs

EMC MM-02-54-03

Access to Document

10.1002/pbc.27083

http://hdl.handle.net/1765/114183

Cite this

Sluis, I., de Groot-Kruseman, H., te Loo, M., Tissing, WJE., van den Bos, C., Kaspers, GJL., Bierings, M., Kollen, WJW., Konig, T., Pichlmeier, U., Kuhnel, HJ., & Pieters, R. (2018). Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group. Pediatric Blood & Cancer, 65(8), Article e27083. https://doi.org/10.1002/pbc.27083

@article{50617fc81f224ff4a6f5e80af6502b23,

title = "Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group",

author = "Inge Sluis and {de Groot-Kruseman}, H and {te Loo}, M and WJE Tissing and {van den Bos}, C and GJL Kaspers and M Bierings and WJW Kollen and T Konig and U Pichlmeier and HJ Kuhnel and Rob Pieters",

year = "2018",

doi = "10.1002/pbc.27083",

language = "Undefined/Unknown",

volume = "65",

journal = "Pediatric Blood & Cancer",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "8",

}

Sluis, I, de Groot-Kruseman, H, te Loo, M, Tissing, WJE, van den Bos, C, Kaspers, GJL, Bierings, M, Kollen, WJW, Konig, T, Pichlmeier, U, Kuhnel, HJ & Pieters, R 2018, 'Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group', Pediatric Blood & Cancer, vol. 65, no. 8, e27083. https://doi.org/10.1002/pbc.27083

Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group. / Sluis, Inge; de Groot-Kruseman, H; te Loo, M et al.
In: Pediatric Blood & Cancer, Vol. 65, No. 8, e27083, 2018.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Efficacy and safety of recombinant E-coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group

AU - Sluis, Inge

AU - de Groot-Kruseman, H

AU - te Loo, M

AU - Tissing, WJE

AU - van den Bos, C

AU - Kaspers, GJL

AU - Bierings, M

AU - Kollen, WJW

AU - Konig, T

AU - Pichlmeier, U

AU - Kuhnel, HJ

AU - Pieters, Rob

PY - 2018

Y1 - 2018

U2 - 10.1002/pbc.27083

DO - 10.1002/pbc.27083

M3 - Article

C2 - 29727043

SN - 1545-5009

VL - 65

JO - Pediatric Blood & Cancer

JF - Pediatric Blood & Cancer

IS - 8

M1 - e27083

ER -